Clinical trial
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection (DME, CRTH258B1401)
NCT05526729 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection (DME, CRTH258B1401)
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 2, 2022
- Completion date
- June 29, 2024
- Enrollment
- 222 (actual)
- Sites
- 76
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema